Fidelity Investments
CBPO

Fidelity Investments’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Fidelity Investments’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14
Closed -$2K – 4799
2020
Q4 		$2K Buy
+14
New +$1.63K ﹤0.01% 3645
2019
Q4 		– Sell
-151,632
Closed -$17.4M – 4526
2019
Q3 		$17.4M Sell
151,632
-151,269
-50% -$15M ﹤0.01% 1625
2019
Q2 		$28.9M Sell
302,901
-117,514
-28% -$11.1M ﹤0.01% 1472
2019
Q1 		$38.4M Sell
420,415
-317,164
-43% -$26M ﹤0.01% 1330
2018
Q4 		$56M Buy
737,579
+289,485
+65% +$21.3M 0.01% 1097
2018
Q3 		$35.8M Buy
448,094
+213,994
+91% +$19.9M ﹤0.01% 1431
2018
Q2 		$23.3M Buy
234,100
+700
+0.3% +$60.5K ﹤0.01% 1648
2018
Q1 		$18.9M Sell
233,400
-77,633
-25% -$6.28M ﹤0.01% 1752
2017
Q4 		$24.5M Sell
311,033
-899,515
-74% -$74.8M ﹤0.01% 1629
2017
Q3 		$112M Sell
1,210,548
-854,721
-41% -$82.1M 0.01% 918
2017
Q2 		$234M Buy
2,065,269
+184,720
+10% +$20.6M 0.03% 622
2017
Q1 		$188M Buy
1,880,549
+406,105
+28% +$43.4M 0.02% 716
2016
Q4 		$159M Buy
1,474,444
+154,792
+12% +$18.1M 0.02% 779
2016
Q3 		$164M Sell
1,319,652
-95,954
-7% -$11.3M 0.02% 770
2016
Q2 		$151M Buy
1,415,606
+44,575
+3% +$5.18M 0.02% 784
2016
Q1 		$157M Buy
1,371,031
+177,838
+15% +$20.9M 0.02% 764
2015
Q4 		$170M Buy
1,193,193
+96,800
+9% +$11.2M 0.02% 719
2015
Q3 		$98.5M Buy
1,096,393
+128,361
+13% +$13.5M 0.01% 958
2015
Q2 		$111M Buy
968,032
+576,847
+147% +$60.6M 0.01% 997
2015
Q1 		$37.4M Buy
+391,185
New +$29.3M ﹤0.01% 1465
2014
Q3 		– Sell
-179,600
Closed -$7.99M – 2866
2014
Q2 		$7.99M Buy
+179,600
New +$7.34M ﹤0.01% 2125

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Fidelity Investments's CBPO Position: Q1 2021 in Review

Fidelity Investments sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 14 shares — an estimated $2K sold.

Fidelity Investments first reported a position in CBPO in Q2 2014 and held it in 21 quarters. The position peaked at $234M in Q2 2017. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • Fidelity Investments reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
  • Fidelity Investments sold 14 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $2K.
  • Fidelity Investments first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 21 quarters.
  • Fidelity Investments's China Biologic Products Holdings, Inc. position peaked at $234M in Q2 2017.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Fidelity Investments's 13F filing for Q1 2021, filed 14 May 2021.